Facts
The International Rugby Board (IRB) alleges that, on 19 June 2008, Andrey Sorokin (the “Player”) committed an Anti-Doping Rule Violation by reason of an Adverse Analytical Finding for Indapamide, which is Prohibited Substance, classed under S5 Diuretics and Other Masking Agents. The Player does not dispute the finding.
History
The player asserts that the finding arose from his medically-prescribed use of a medicine called Noliprel to treat a serious cardiac condition. Noliprel contains indapamide.
Decision
On 19 June 2008, the Player committed an Anti-Doping Rule Violation by reason of the presence of Indapamide in his bodily Sample. Indapamide is a Prohibited Substance under both Regulation 21 and the World Anti-Doping Code, classed under S5 Diuretics and Other Masking Agents. The sanction imposed for this Anti-Doping Rule Violation is a warning and a reprimand. The Player’s provisional suspension is lifted with immediate effect and he is, subject to compliance with all other applicable laws and regulations, eligible to participate in the Game.
Costs
Written submissions should be submitted on time
